💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Biogen Inc. (BIIB)
« Back to company indexBIIB Chatter Timeline
Stock Ticker for BIIB
Most Active Tweeters for BIIB
| User | Tweets |
|---|---|
| @TradingSin21 | 11 |
| @bthefirsttoknow | 8 |
| @Biohazard3737 | 6 |
| @Jarvis_Alerts | 6 |
| @TradeWithAlerts | 5 |
Recent Tweets for BIIB
 |
@TradingSin21 $BIIB Trading Ideas | Awaiting Buy signal. 77.78% Profitability based on 11 trades. Profit factor is 4.96. Learn mo… https://t.co/C8KXlK5LW2 1:09am |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in BIOGEN INC. COMMON STOCK $BIIB https://t.co/jJxL4zXXlM September 25th 2022, 7:09pm |
 |
@Tickeron $BIIB's 10-day Moving Average crossed below its 50-day Moving Average on August 26, 2022. View odds for this and ot… https://t.co/r5TsQSjU73 September 25th 2022, 10:09am |
 |
@FlashAlert_me $BIIB [15s. delayed]: Issued Press Release on September 19, 13:41:00: INVESTIGATION ALERT: Scott+Scott Attorneys at… https://t.co/50rCkMjtJI September 25th 2022, 2:09am |
|
@TradingSin21 $BIIB Trading Ideas | Awaiting Buy signal. 77.78% Profitability based on 11 trades. Profit factor is 4.96. Learn mo… https://t.co/9Do6gx0uHY September 25th 2022, 1:09am |
 |
@youlhacairang $BIIB 1 min charts, short bias, entry under inside candle, yellow line. Covered by scale out, almost bottom ticked… https://t.co/09UmTXOoh6 September 24th 2022, 7:09pm |
 |
@Gambiste1 RT @RNAiAnalyst: Surprised at biotwitter giving $BIIB and amyloid hypothesis benefit of doubt regarding upcoming #lecanemab data... ...no… September 24th 2022, 2:09pm |
 |
@RNAiAnalyst Surprised at biotwitter giving $BIIB and amyloid hypothesis benefit of doubt regarding upcoming #lecanemab data...… https://t.co/wii3OyEoK0 September 24th 2022, 1:09pm |
|
@Tickeron $BIIB's 10-day Moving Average broke below its 50-day Moving Average on August 26, 2022. View odds for this and othe… https://t.co/G8OSENWKN2 September 24th 2022, 10:09am |
 |
@TradeWithAlerts Nice print for $BIIB Size: 175260 Price: 197.78 Amount: $34,662,922.80 Time: 1600 See more: https://t.co/FermWOFDda… https://t.co/A8HOSDUWmM September 23rd 2022, 8:09pm |
 |
@optioncharts $BIIB Implied Volatility expiration 09/23/2022 #maxpain #options https://t.co/uwH9spy9LL https://t.co/HHTCZLIh4y September 23rd 2022, 5:09pm |
 |
@OptionsProOI #Biogen $BIIB Has An Excellent #Fundamental Analysis Score (FA Score). Check various FA Indicators' value, score, 5… https://t.co/tfyFXmarBV September 23rd 2022, 4:09pm |
 |
@LeviTrade2 $BIIB Bullish technical pattern based on 7 trades. Start Free Trial at https://t.co/z546jb65wN .#BIIB #tradingideas… https://t.co/3546J5WRwm September 23rd 2022, 4:09pm |
 |
@BioValues $BIIB do we get Alzheimer's data Monday? Or will it be following week? Any predictions? September 23rd 2022, 2:09pm |
 |
@MarcJacksonLA $BIIB Biogen offloads nearly $600M in Cambridge real estate — making room for a Broad Institute expansion - https://t.co/1Z4R77GSb1 September 23rd 2022, 2:09pm |
 |
@i_tradeoptions Took a position in $BIIB after positive trial news flow. Scares me to death bc its too easy. Smells like trap. SEP… https://t.co/qhU6QAeCOM September 23rd 2022, 12:09pm |
 |
@newsfilterio $BIIB Truist Securities analyst Robyn Karnauskas maintains Biogen with a Buy and lowers the price target from $270… https://t.co/xaaF5jgUJI September 23rd 2022, 1:09am |
|
@LeviTrade2 $BIIB Waiting for Buy signal based on 7 trades. Learn more at https://t.co/d0Hu3BtZFG https://t.co/EhWETB7FFE September 22nd 2022, 11:09pm |
 |
@dailycandlestix $BIIB Below Avg Volume Daily appearances since 2010: 160 Close 5 days later ±: Avg: -1.98 SD: 11.69 Worst: -80.31 B… https://t.co/CVbjht0hJs September 22nd 2022, 8:09pm |
|
@LeviTrade2 $BIIB Bullish pattern building based on 6 trades. Free 7-Day trial at https://t.co/z546jb65wN https://t.co/k6eplY8Qqy September 22nd 2022, 5:09pm |
|
@MarcJacksonLA $BIIB Biogen throws itself back into muddled data arguments with more details on its antisense ALS drug - https://t.co/gHSy8z8bdH September 22nd 2022, 5:09pm |
 |
@communiststocks Biogen Inc - $BIIB ? QUOTE $BIIB is UP ? on Thu Sep 22 Currently at 200.13 USD for a 0.40% gain from previous clos… https://t.co/KHENhQWX95 September 22nd 2022, 4:09pm |
 |
@SnupSnus @bigpharmaguy @Biohazard3737 The biggest value determinant for $BIIB outside of the AD readout are clearly the CD-2… https://t.co/t8YamqkJuY September 22nd 2022, 3:09pm |
 |
@ivolatility Biogen $BIIB 30-day IV index mean is at 96; compared to its 52-week range of 30 to 101 into topline data https://t.co/1yfSe6QQBv September 22nd 2022, 3:09pm |
 |
@mRNAdisrupts #Tofersen for #Sod1 #ALS. Blue represents placebo (late adopters). . $biib $ions https://t.co/lqiBFBC4v2 September 22nd 2022, 2:09pm |
 |
@darylmox RT @BioValues: $BIIB good point. If Alz data is coming before end of September it will likely be over the weekend going into Monday: https:… September 22nd 2022, 2:09pm |
|
@BioValues $BIIB good point. If Alz data is coming before end of September it will likely be over the weekend going into Monda… https://t.co/8OwmU4PNCK September 22nd 2022, 2:09pm |
|
@mRNAdisrupts #Tofersen placebo delayed start (blue). $biib $ions #neurology https://t.co/Q8IUAwQ9vh September 22nd 2022, 2:09pm |
|
@BioValues $CYCN next week marks the end of q3 and two months since CIAS data readout and bank hired. Plus the $BIIB Alzheimer… https://t.co/jvXey7FzC8 September 22nd 2022, 2:09pm |
 |
@bthefirsttoknow First out// $BIIB: Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE https://t.co/EeVvqjr9p7 September 22nd 2022, 2:09pm |
 |
@harshdeuskar RT @Biohazard3737: If CLARITY-AD is positive, $BIIB could be a huge turnaround story. VALOR data in NEJM looked really good. And the data… September 22nd 2022, 1:09pm |
 |
@Biohazard3737 If CLARITY-AD is positive, $BIIB could be a huge turnaround story. VALOR data in NEJM looked really good. And the… https://t.co/tfCEGPldbP September 22nd 2022, 1:09pm |
 |
@Jarvis_Alerts $BIIB [Biogen]: Truist Securities Maintains Buy Lowers Price Target $270 --> 265 Sign-up free for beta ver.:… https://t.co/rSxauKzC6C September 22nd 2022, 1:09pm |
|
@bthefirsttoknow First out// $BIIB: Longer-Term Use, Early Initiation of Biogen's Experimental Drug For Inherited Rare Disease Slows Disease September 22nd 2022, 12:09pm |
|
@Jarvis_Alerts $BIIB 305C Exp:18-Nov-22 ?? ? Total(Day): $53,300 #UnusualActivity Sign-up free for beta ver.:… https://t.co/ZQyuxjqzle September 22nd 2022, 12:09pm |
 |
@Ainvest_Wire Truist Securities maintains buy on Biogen, lowers price target to $265 $BIIB View more: https://t.co/lTXh1dzMi0… https://t.co/neLJHX0Do9 September 22nd 2022, 11:09am |
|
@bthefirsttoknow First out// $BIIB: Truist Securities Maintains Buy on Biogen, Lowers Price Target to $265 https://t.co/ifG1k6fdfg September 22nd 2022, 11:09am |
 |
@theflynews UBS upgrades Eli Lilly to Buy, says most attractive in big pharma $LLY $BIIB https://t.co/98ObpRIJYy September 22nd 2022, 10:09am |
|
@Tickeron $BIIB's 10-day Moving Average crossed below its 50-day Moving Average on August 26, 2022. View odds for this and ot… https://t.co/sJy1kw3Omg September 22nd 2022, 9:09am |
|
@TradingSin21 $BIIB Trading Ideas | Awaiting Buy signal. 71.43% Profitability based on 7 trades. Profit factor is 3.68. Learn mor… https://t.co/TdlryHmTyX September 22nd 2022, 9:09am |
|
@Biohazard3737 Something to consider for the $BIIB bears: Expedition 3 (Solanuzumab) would have been stat sig had $LLY chosen CDR… https://t.co/FY6Ctq0lOa September 22nd 2022, 3:09am |
 |
@BIOTECHBATMAN Biogen says ALS drug shows clinical benefit in new data analysis $biib $ions https://t.co/kKG6EXgAG4 September 22nd 2022, 1:09am |
|
@optioncharts $BIIB high OI range is 192.50 to 210.00 for option expiration 09/23/2022 PutCallRatio=0.75 #maxpain #options… https://t.co/TpzM5Az4PU September 22nd 2022, 1:09am |
|
@LeviTrade2 $BIIB Waiting for Buy signal based on 6 trades. Learn more at https://t.co/d0Hu3BtZFG https://t.co/EEMTF5z3yE September 22nd 2022, 12:09am |
|
@FlashAlert_me $BIIB [15s. delayed]: Issued Press Release on September 21, 17:15:00: The New England Journal of Medicine Publishes… https://t.co/Q6TlcWzSAB September 21st 2022, 9:09pm |
 |
@StockIlluminat1 $BIIB - https://t.co/7ZaXsmvBeu - The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Ben… https://t.co/XN0xewYogp September 21st 2022, 9:09pm |
|
@bthefirsttoknow First out// $BIIB: The New England Journal of Medicine Publishes Tofersen Data that Show Benefits in Rare, Genetic… https://t.co/oJ8mYGug1N September 21st 2022, 9:09pm |
 |
@StockNewsBot2 $BIIB The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Benefits in Rare, Genetic Form… https://t.co/87HCADpcfR September 21st 2022, 9:09pm |
 |
@FastestAlert $BIIB The New England Journal Of Medicine Publishes Pivotal Tofersen Data That Show Benefits In Rare, Genetic Form… https://t.co/Jkx5sWKJrk September 21st 2022, 9:09pm |
 |
@stock_titan $BIIB The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Benefits in Rare, Genetic Form… https://t.co/F3A5ryBz36 September 21st 2022, 9:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.